Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

2021 Efficacy Data Review in Relapsed CLL: BTK Inhibitors, Ven+/-Rituximab, LOXO-305

145 views
June 11, 2021
Comments 0
Login to view comments. Click here to Login